MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$144,735K
(52.03%↑ Y/Y)
Interest income
$9,302K
(-32.64%↓ Y/Y)
Loss before income
taxes
-$144,689K
(52.11%↑ Y/Y)
Provision (benefit) for
income taxes
$46K
(111.70%↑ Y/Y)
Total other income,
net
$8,602K
(-31.70%↓ Y/Y)
Other expense, net
-$700K
(42.34%↑ Y/Y)
Loss from operations
-$153,291K
(51.29%↑ Y/Y)
Total operating
expenses
$153,291K
(-61.88%↓ Y/Y)
Research and development
$90,404K
(-13.14%↓ Y/Y)
Selling, general and
administrative
$62,887K
(-45.00%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Amylyx Pharmaceuticals, Inc. (AMLX)
Amylyx Pharmaceuticals, Inc. (AMLX)